COPD care delivery pathways in five European union countries: Mapping and health care professionals’ perceptions

International Journal of COPD

Volumn 11, Issue 1, 2016, Pages 2831-2838

  Kayyali, Reem ^a   Odeh, Bassel ^a   Frerichs, Inéz ^b   Davies, Nikki ^c   Perantoni, Eleni ^d   D’Arcy, Shona ^e   Vaes, Anouk W ^f   Chang, John ^c   Spruit, Martijn A ^f   Deering, Brenda ^g   Philip, Nada ^a   Siva, Roshan ^c   Kaimakamis, Evangelos ^h   Chouvarda, Ioanna ^h   Pierscionek, Barbara ^a   Weiler, Norbert ^b   Wouters, Emiel F M ^f   Raptopoulos, Andreas ⁱ   Nabhani Gebara, Shereen ^a  

^a KINGSTON UNIVERSITY   (United Kingdom)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^c MAYDAY UNIVERSITY HOSPITAL   (United Kingdom)

^d AHEPA UNIVERSITY HOSPITAL   (Greece)

^e ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^f Centre of Expertise for Chronic Organ Failure   (Netherlands)

^g BEAUMONT HOSPITAL   (Ireland)

^h ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

ⁱ EXODUS SA   (Greece)

Author keywords

Care delivery pathway; Comorbidities; Comparative analysis; COPD

Indexed keywords

ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONTROLLED STUDY; ENGLAND; GEOGRAPHIC DISTRIBUTION; GERMANY; GREECE; HEALTH CARE DELIVERY; HEALTH PERSONNEL ATTITUDE; HUMAN; IRELAND; LENGTH OF STAY; MEDICAL SERVICE; NETHERLANDS; OUTCOME ASSESSMENT; PATIENT ATTITUDE; PROFESSIONAL KNOWLEDGE; CLINICAL PATHWAY; CLINICAL PRACTICE; CLINICAL TRIAL; COMPARATIVE STUDY; COOPERATION; EUROPE; EUROPEAN UNION; HEALTH CARE DISPARITY; HEALTH CARE SURVEY; INTEGRATED HEALTH CARE SYSTEM; INTERDISCIPLINARY COMMUNICATION; INTERVIEW; MULTICENTER STUDY; PATHOPHYSIOLOGY; PATIENT CARE; PERCEPTION; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITATIVE RESEARCH; TRENDS;

ATTITUDE OF HEALTH PERSONNEL; COOPERATIVE BEHAVIOR; CRITICAL PATHWAYS; DELIVERY OF HEALTH CARE, INTEGRATED; EUROPE; EUROPEAN UNION; HEALTH CARE SURVEYS; HEALTHCARE DISPARITIES; HUMANS; INTERDISCIPLINARY COMMUNICATION; INTERVIEWS AS TOPIC; PATIENT CARE TEAM; PERCEPTION; PRACTICE PATTERNS, PHYSICIANS'; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITATIVE RESEARCH;

EID: 84995639271     PISSN: 11769106     EISSN: 11782005     Source Type: Journal    
DOI: 10.2147/COPD.S104136     Document Type: Article

References (61)

1. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS; GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med. 2001;163(5):1256–1276.
2. European Lung Foundation. Lung diseases – COPD. Lung disease & information. 2012. Available from: http://www.europeanlung.org/en/lung-disease-and-information/lung-diseases/copd. Accessed December 9, 2014.
3. Smith C, Gribbin J, Challen K, Hubbard R. The impact of the 2004 NICE guideline and 2003 General Medical Services contract on COPD in primary care in the UK. QJM. 2008;101(2):145–153.
4. European Respiratory Society. The economic burden of lung disease. In: Gibson J, Loddenkemper R, Sibille Y, Lundbäck B, editors. European Respiratory Society’s White Book. Sheffield: European Respiratory Society; 2013.
5. OECD. Health expenditure and financing. OECD statistics-health. 2015. Available from: http://stats.oecd.org/Index.aspx?DataSetCode=SHA. Accessed March 20, 2015.
6. European Respiratory Society. Chronic obstructive pulmonary disease. In: European Respiratory Society’s White Book. Gibson J, Loddenkemper R, Sibille Y, Lundbäck B, editors. Sheffield: European Respiratory Society; 2013.
7. Geldmacher H, Biller H, Herbst A, et al. Die Prävalenz der chronisch obstruktiven Lungenerkrankung (COPD) in Deutschland. [The prevalence of chronic obstructive pulmonary disease (COPD) in Germany. Results of the BOLD study]. Dtsch Med Wochenschr. 2008;133(50):2609–2614. German.
8. Irish Thoracic Society. National Respiratory COPD Framework. Dublin: Irish Thoracic Society; 2008.
9. Rutten FH, Moons KG, Cramer M-JM, Grobbee DE, Zuithoff NP, Hoes AW. Recognising heart failure in elderly patients with stable chronic obstructive pulmonary disease in primary care: cross sectional diagnostic study. BMJ. 2005;331(7529):1379.
10. Chatila WM, Thomashow BM, Minai OA, Criner GJ, Make BJ. Comorbidities in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2008;5(4):549–555.
11. Corsonello A, Incalzi RA, Pistelli R, Pedone C, Bustacchini S, Lattanzio F. Comorbidities of chronic obstructive pulmonary disease. Curr Opin Pulm Med. 2011;17 (Suppl 1):S21–S28.
12. Burgel P-R, Escamilla R, Perez T, et al; INITIATIVES BPCO Scientific Committee. Impact of comorbidities on COPD-specific health-related quality of life. Respir Med. 2013;107(2):233–241.
13. Lou P, Zhu Y, Chen P, et al. Prevalence and correlations with depression, anxiety, and other features in outpatients with chronic obstructive pulmonary disease in China: a cross-sectional case control study. BMC Pulm Med. 2012;12(1):53.
14. Nolte E, McKee M, Knai C. Managing chronic conditions: An introduction to the experience in eight countries. In: Nolte E, McKee M, Knai C, editors. Managing chronic conditions Experience in eight countries. Copenhagen: WHO Regional Office Europe; 2008.
15. Nolte E, McKee M. Caring for People with Chronic Conditions: A Health System Perspective. Glasgow: McGraw-Hill International; 2008.
16. Titova E, Steinshamn S, Indredavik B, Henriksen AH. Long term effects of an integrated care intervention on hospital utilization in patients with severe COPD: a single centre controlled study. Respir Res. 2015;16(1):8.
17. See C, Chua G, Choo Y, Wu C, Chee T. Implementation of a COPD Integrated Care Pathway (ICP) programme to improve outcomes of COPD patients. Int J Integr Care. 2013;13(8):1472.
18. Balestracci S, Porcu A, Vignale L, et al. Cost and effectiveness of integrated care intervention on the patients with COPD. Eur Respir J. 2013;42(Suppl 57):P5103.
19. Koff P, Jones RH, Cashman JM, Voelkel NF, Vandivier R. Proactive integrated care improves quality of life in patients with COPD. Eur Respir J. 2009;33(5):1031–1038.
20. Lemmens KM, Nieboer AP, Huijsman R. A systematic review of integrated use of disease-management interventions in asthma and COPD. Respir Med. 2009;103(5):670–691.
21. Casas A, Troosters T, Garcia-Aymerich J, et al. Integrated care prevents hospitalisations for exacerbations in COPD patients. Eur Respir J. 2006;28(1):123–130.
22. Hernández C, Alonso A, Garcia-Aymerich J, et al. Effectiveness of community-based integrated care in frail COPD patients: a randomised controlled trial. NPJ Prim Care Respir Med. 2015;25:15022.
23. Garcia-Aymerich J, Hernandez C, Alonso A, et al. Effects of an integrated care intervention on risk factors of COPD readmission. Respir Med. 2007;101(7):1462–1469.
24. Mak V, D’Ancona G, Rampersad R, Saleem A, Khambh J. Reducing inappropriate high dose ICS prescribing for COPD in primary care using respiratory integrated care virtual clinics. Eur Respir J. 2015;46(Suppl 59):PA3859.
25. Cecile MA, Maarse JAM, Onno CP, Boudewijn LP, Maureen PMH, Frank WJM. Care delivery pathways for Chronic Obstructive Pulmonary Disease in England and the Netherlands: a comparative study. Int J Integr Care. 2012;12:1–9.
26. Ovretveit J. An introduction to comparative health research. In: Comparative and Cross-Cultural Health Research: A Practical Guide. Ovretveit J, editor. Oxon: Radcliffe Publishing; 1998:1–25.
27. Nabhani-Gebara S, Kayyali R, Philip N, et al. WELCOME project: what do stakeholders want? In depth analysis of COPD patients, carers and healthcare professional views. Paper presented at: Wireless Mobile Communication and Healthcare (Mobihealth), 2014 EAI 4th International Conference; November 3–5, 2014; Athens, Greece.
28. Burnard P. A method of analysing interview transcripts in qualitative research. Nurse Educ Today. 1991;11(6):461–466.
29. Burnard P, Gill P, Stewart K, Treasure E, Chadwick B. Analysing and presenting qualitative data. Br Dent J. 2008;204(8):429–432.
30. Fearon P, Langhorne P. Services for reducing duration of hospital care for acute stroke patients. Cochrane Database Syst Rev. 2012;(9):CD000443.
31. Coleman EA, Boult C. Improving the quality of transitional care for persons with complex care needs. J Am Geriatr Soc. 2003;51(4): 556–557.
32. Nolte E, Knai C, Saltman RB. Assessing chronic disease management in European health systems Copenhagen: WHO Regional Office Europe; 2014.
33. Leape L, Berwick D, Clancy C, et al. Transforming healthcare: a safety imperative. Qual Saf Health Care. 2009;18(6):424–428.
34. European Lung Foundation. Lung diseases – COPD. Lung disease & information. 2012. Available from: http://www.europeanlung.org/en/lung-disease-and-information/lung-diseases/copd. Accessed December 9, 2014.
35. Martínez-González NA, Berchtold P, Ullman K, Busato A, Egger M. Integrated care programmes for adults with chronic conditions: a meta-review. Int J Qual Health Care. 2014;26(5):561–570.
36. Lemmens KM, Lemmens LC, Boom JH, et al. Chronic care management for patients with COPD: a critical review of available evidence. J Eval Clin Pract. 2013;19(5):734–752.
37. Adams SG, Smith PK, Allan PF, Anzueto A, Pugh JA, Cornell JE. Systematic review of the chronic care model in chronic obstructive pulmonary disease prevention and management. Arch Intern Med. 2007;167(6):551–561.
38. Niesink A, Trappenburg J, De Weert-van Oene G, Lammers J, Verheij T, Schrijvers A. Systematic review of the effects of chronic disease management on quality-of-life in people with chronic obstructive pulmonary disease. Respir Med. 2007;101(11):2233–2239.
39. Khdour MR, Kidney JC, Smyth BM, McElnay JC. Clinical pharmacy‐led disease and medicine management programme for patients with COPD. Br J Clin Pharmacol. 2009;68(4):588–598.
40. Mehuys E, Boussery K, Adriaens E, et al. COPD management in primary care: an observational, community pharmacy-based study. Ann Pharmacother. 2010;44(2):257–266.
41. Jarab AS, AlQudah SG, Khdour M, Shamssain M, Mukattash TL. Impact of pharmaceutical care on health outcomes in patients with COPD. Int J Clin Pharm. 2012;34(1):53–62.
42. Ottenbros S, Teichert M, de Groot R, et al. Pharmacist-led intervention study to improve drug therapy in asthma and COPD patients. Int J Clin Pharm. 2014;36(2):336–344.
43. Wright D, Twigg M, Thornley T. Chronic obstructive pulmonary disease case finding by community pharmacists: a potential cost-effective public health intervention. Int J Pharm Pract. 2015;23(1):83–85.
44. Glendinning C, Tjadens F, Arksey H, Moree M, Moran N, Nies H. Care provision within families and its socio-economic impact on care providers: report for the European Commission DG EMPL negotiated procedure VT/2007/114. York: University of York; 2009.
45. Cicutto L, Brooks D, Henderson K. Self-care issues from the perspective of individuals with chronic obstructive pulmonary disease. Patient Educ Couns. 2004;55(2):168–176.
46. Ek K, Ternestedt BM. Living with chronic obstructive pulmonary disease at the end of life: a phenomenological study. J Adv Nurs. 2008;62(4):470–478.
47. Halding A-G, Wahl A, Heggdal K. ‘Belonging’. Patients’ experiences of social relationships during pulmonary rehabilitation. Disabil Rehabil. 2010;32(15):1272–1280.
48. Kanervisto M, Kaistila T, Paavilainen E. Severe chronic obstructive pulmonary disease in a family’s everyday life in Finland: perceptions of people with chronic obstructive pulmonary disease and their spouses. Nurs Health Sci. 2007;9(1):40–47.
49. Bourbeau J. Clinical decision processes and patient engagement in self-management. Dis Manage Health Outcomes. 2008;16(5):327–333.
50. Jassem E, Kozielski J, Górecka D, Krakowiak P, Krajnik M, Slominski JM. Integrated care for patients with advanced chronic obstructive pulmonary disease: a new approach to organization. Pol Arch Med Wewn. 2010;120(10):423–428.
51. Grant M, Cavanagh A, Yorke J. The impact of caring for those with chronic obstructive pulmonary disease (COPD) on carers’ psychological well-being: a narrative review. Int J Nurs Stud. 2012;49(11):1459–1471.
52. Disler R, Gallagher R, Davidson P. Factors influencing self-management in chronic obstructive pulmonary disease: an integrative review. Int J Nurs Stud. 2012;49(2):230–242.
53. Mäkelä MJ, Backer V, Hedegaard M, Larsson K. Adherence to inhaled therapies, health outcomes and costs in patients with asthma and COPD. Respir Med. 2013;107(10):1481–1490.
54. Vestbo J, Anderson JA, Calverley PM, et al. Adherence to inhaled therapy, mortality and hospital admission in COPD. Thorax. 2009;64(11):939–943.
55. Lareau SC, Yawn BP. Improving adherence with inhaler therapy in COPD. Int J Chron Obstruct Pulmon Dis. 2010;5:401–406.
56. Smitha SM, Elkina SL, Partridgeb MR. Technology and its role in respiratory care. Prim Care Respir J. 2009;18(3):159–164.
57. Inglis S. Structured telephone support or telemonitoring programmes for patients with chronic heart failure. J Evid Based Med. 2010;3(4):228.
58. Polisena J, Tran K, Cimon K, et al. Home telehealth for chronic obstructive pulmonary disease: a systematic review and meta-analysis. J Telemed Telecare. 2010;16(3):120–127.
59. McLean S, Nurmatov U, Liu J, Pagliari C, Car J, Sheikh A. Telehealthcare for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2011;(7):CD007718.
60. Purcell R, McInnes S, Halcomb EJ. Telemonitoring can assist in managing cardiovascular disease in primary care: a systematic review of systematic reviews. BMC Fam Pract. 2014;15(1):43.
61. Cruz J, Brooks D, Marques A. Home telemonitoring effectiveness in COPD: a systematic review. Int J Clin Pract. 2014;68(3):369–378.